These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 9115588

  • 1. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV, Carbajal S, Kang H, Viaje A, Slaga TJ.
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [Abstract] [Full Text] [Related]

  • 2. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
    Spiegelman VS, Budunova IV, Carbajal S, Slaga TJ.
    Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
    [Abstract] [Full Text] [Related]

  • 3. Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
    Kowalczyk P, Kinjo T, Kowalczyk M, Walaszek Z, Hanausek M, Slaga TJ.
    Eur J Pharmacol; 2009 May 21; 610(1-3):29-36. PubMed ID: 19306867
    [Abstract] [Full Text] [Related]

  • 4. Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription.
    Kinjo T, Kowalczyk P, Kowalczyk M, Walaszek Z, Nishimaki T, Slaga TJ, Hanausek M.
    Mol Carcinog; 2009 Dec 21; 48(12):1123-30. PubMed ID: 19575421
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis.
    Budunova IV, Kowalczyk D, Pérez P, Yao YJ, Jorcano JL, Slaga TJ.
    Oncogene; 2003 May 22; 22(21):3279-87. PubMed ID: 12761498
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K, Beltrán L, Rupp T, DiGiovanni J.
    Mol Carcinog; 1998 Jun 22; 22(2):73-83. PubMed ID: 9655251
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
    Rho O, Bol DK, You J, Beltrán L, Rupp T, DiGiovanni J.
    Mol Carcinog; 1996 Oct 22; 17(2):62-9. PubMed ID: 8890954
    [Abstract] [Full Text] [Related]

  • 8. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E, Muga SJ, Locniskar MF, Fischer SM.
    Mol Carcinog; 1999 Apr 22; 24(4):276-86. PubMed ID: 10326864
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.
    Cancer Res; 2001 Feb 01; 61(3):970-6. PubMed ID: 11221892
    [Abstract] [Full Text] [Related]

  • 10. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 11. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D.
    Cancer Res; 2003 Feb 01; 63(3):567-72. PubMed ID: 12566297
    [Abstract] [Full Text] [Related]

  • 12. Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse.
    Mustacich D, Wagner A, Williams R, Bair W, Barbercheck L, Stratton SP, Bhattacharyya AK, Powis G.
    Carcinogenesis; 2004 Oct 01; 25(10):1983-9. PubMed ID: 15166090
    [Abstract] [Full Text] [Related]

  • 13. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH, Juliana MM, Hicks PH, Feng G, Elmets C, Liaw L, Chang PL.
    Cancer Res; 2006 Jul 15; 66(14):7119-27. PubMed ID: 16849558
    [Abstract] [Full Text] [Related]

  • 14. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL, Johnson GR, Gallagher PM, Stockman SL, Sundberg JP, Conti CJ.
    Cancer Res; 1998 Oct 01; 58(19):4314-23. PubMed ID: 9766659
    [Abstract] [Full Text] [Related]

  • 15. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
    Bhasin G, Kauser H, Athar M.
    Arch Toxicol; 2004 May 01; 78(5):283-9. PubMed ID: 14997284
    [Abstract] [Full Text] [Related]

  • 16. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
    Meeran SM, Vaid M, Punathil T, Katiyar SK.
    Carcinogenesis; 2009 Mar 01; 30(3):520-8. PubMed ID: 19158151
    [Abstract] [Full Text] [Related]

  • 17. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM, Watt FM.
    Cancer Res; 2001 Jul 01; 61(13):5248-54. PubMed ID: 11431366
    [Abstract] [Full Text] [Related]

  • 18. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors.
    Budunova IV, Carbajal S, Viaje A, Slaga TJ.
    Mol Carcinog; 1996 Mar 01; 15(3):190-201. PubMed ID: 8597532
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD, Scribner NK, McKnight B, Mottet NK.
    Cancer Res; 1983 May 01; 43(5):2034-41. PubMed ID: 6403231
    [Abstract] [Full Text] [Related]

  • 20. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH, Conti CJ, DiGiovanni J.
    Cancer Res; 1987 Jul 15; 47(14):3783-90. PubMed ID: 3109733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.